Orexigen Therapeutics recalls

Orexigen Therapeutics appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2018-11-14.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Contrave (naltrexone HCl and bupropion HCl)
  FDA Drug · Class III · 2018-11-14 · Orexigen Therapeutics
• Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therap…
  FDA Drug · Class III · 2018-08-22 · Orexigen Therapeutics